XML 46 R30.htm IDEA: XBRL DOCUMENT v3.24.3
Segment Information (Tables)
 3 Months Ended
Sep. 30, 2024
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
Revenue
The following table presents revenue for the two reportable segments and disaggregated revenue within the remaining operating segments, included in Other, and Corporate:
Three Months Ended September 30,
(in millions)20242023
Pharmaceutical and Specialty Solutions$47,990 $50,588 
Global Medical Products and Distribution3,123 3,032 
Nuclear and Precision Health Solutions373 324 
at-Home Solutions739 667 
OptiFreight® Logistics
74 60 
Other1,186 1,051 
Total segment revenue
52,299 54,671 
Corporate (1)(22)(21)
Total revenue$52,277 $54,650 
(1)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Revenue from External Customers by Geographic Areas [Table Text Block]
The following table presents revenue by geographic area:
Three Months Ended September 30,
(in millions)20242023
United States$51,891 $54,270 
International408 401 
Total segment revenue
52,299 54,671 
Corporate (1)(22)(21)
Total revenue$52,277 $54,650 
(1)Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Segment Profit by Reportable Segment
The following table presents segment profit for the two reportable segments and the remaining operating segments, included in Other, and Corporate:
Three Months Ended September 30,
(in millions)20242023
Pharmaceutical and Specialty Solutions$530 $456 
Global Medical Products and Distribution8 12 
Other (1)104 96 
Total segment profit642 564 
Corporate(74)(596)
Total operating earnings/(loss)
$568 $(32)
(1)     Comprised of the remaining operating segments, Nuclear and Precision Health Solutions, at-Home Solutions, and OptiFreight® Logistics.
Assets by Reportable Segment
The following table presents total assets for two reportable segments and the remaining operating segments, included in Other, and Corporate:
(in millions)September 30, 2024June 30, 2024
Pharmaceutical and Specialty Solutions$29,215 $29,149 
Global Medical Products and Distribution7,148 7,047 
Other2,611 2,606 
Corporate
4,085 6,319 
Total assets$43,059 $45,121